Cite
Pinder EM, Atwal GS, Ayantunde AA, et al. Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571). Sarcoma. 2007;2007:82012doi: 10.1155/2007/82012.
Pinder, E. M., Atwal, G. S., Ayantunde, A. A., Khan, S., Sokal, M., McCulloch, T., & Parsons, S. L. (2007). Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571). Sarcoma, 200782012. https://doi.org/10.1155/2007/82012
Pinder, Elizabeth M, et al. "Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)." Sarcoma vol. 2007 (2007): 82012. doi: https://doi.org/10.1155/2007/82012
Pinder EM, Atwal GS, Ayantunde AA, Khan S, Sokal M, McCulloch T, Parsons SL. Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571). Sarcoma. 2007;2007:82012. doi: 10.1155/2007/82012. PMID: 18274611; PMCID: PMC2225466.
Copy
Download .nbib